Display Settings:

Format

Send to:

Choose Destination
    Dermatol Clin. 2007 Jul;25(3):353-62, ix.

    New and experimental treatments of cloasma and other hypermelanoses.

    Source

    Laboratory of Cutaneous Physiopathology, San Gallicano Dermatological Institute (IRCCS), Elio Chianesi, 53, 00144 Rome, Italy. picardo@ifo.it

    Abstract

    In clinical practice, acquired hyperpigmentations represent the most common disorders of pigmentation the dermatologist has to treat. Despite the large number of depigmenting agents available, the treatment of hyperpigmentations is often unsuccessful and disappointing and is still a challenge for dermatologists. This article focuses on the chemical compounds reported to be in depigmenting or skin lightening agents, their proposed mechanism of action, and their clinical efficacy in the treatment of melasma and hypermelanoses, mainly based on randomized clinical trials. It also reviews chemical peels and their indications, together with the possible uses of laser and intense pulsed light.

    PMID:
    17662901
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk